SpliceMutr enables pan-cancer analysis of splicing-derived neoantigen burden in tumors
T. Palmer, M. D. Kessler, X. M. Shao, A. Balan, M. Yarchoan, N. Zaidi, T. Y. Lopez-Vidal, A. Saeed, J. Gore, N. Azad, E. Jaffee, A. V. Favorov, V. Anagnostou, R. Karchin, D. Gaykalova, , E. J. Fertig
SpliceMutr quantifies splicing-derived neoantigens across cancers, finding correlations with immune biomarkers and treatment response.
bioRxiv · May 26, 2023Cancer Biology